Moderna is set to receive $176 million in federal funding to develop a human vaccine against bird flu following outbreaks of the virus in dairy cows across several states, the Department of Health ...

The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, according to the ...

Moderna has secured $176 million in federal funding to develop mRNA vaccines against a potential bird flu pandemic, the Boston-based company announced Tuesday, a move that could bolster U.S ...

How a bird flu pandemic could emerge 06:21. The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses ...

HHS cancels $590 million contract with Moderna for bird flu vaccine By . Katherine Dillinger. PUBLISHED May 28, 2025, 7:49 PM ET. ... Avian influenza, or bird flu, ...

The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu.

Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of ...

Moderna will receive $176 million to develop a pandemic flu vaccine for humans following a concerning outbreak of bird flu in dairy cows across the country, federal officials announced Tuesday.

U.S. Ends $600M Moderna Bird Flu Vaccine Contract THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a vaccine for bird ...

A Moderna spokesperson told MassLive the company is preparing to advance its bird flu vaccine (mRNA-1018) into a phase 3 study, “based on the positive preliminary data from the Phase 1/2 study.” ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.

A Moderna spokesperson told MassLive the company is preparing to advance its bird flu vaccine (mRNA-1018) into a phase 3 study, “based on the positive preliminary data from the Phase 1/2 study.” ...